Literature DB >> 14978303

Directed discovery of bivalent peptide ligands to an SH3 domain.

Monique R Ferguson1, Xiuzhen Fan, Munia Mukherjee, Jinquan Luo, Raza Khan, Josephine C Ferreon, Vincent J Hilser, Robert E Shope, Robert O Fox.   

Abstract

The Caenorhabditis elegans SEM-5 SH3 domains recognize proline-rich peptide segments with modest affinity. We developed a bivalent peptide ligand that contains a naturally occurring proline-rich binding sequence, tethered by a glycine linker to a disulfide-closed loop segment containing six variable residues. The glycine linker allows the loop segment to explore regions of greatest diversity in sequence and structure of the SH3 domain: the RT and n-Src loops. The bivalent ligand was optimized using phage display, leading to a peptide (PP-G(4)-L) with 1000-fold increased affinity for the SEM-5 C-terminal SH3 domain over that of a natural ligand. NMR analysis of the complex confirms that the peptide loop segment is targeted to the RT and n-Src loops and parts of the beta-sheet scaffold of this SH3 domain. This binding region is comparable to that targeted by a natural non-PXXP peptide to the p67(phox) SH3 domain, a region not known to be targeted in the Grb2 SH3 domain family. PP-G(4)-L may aid in the discovery of additional binding partners of Grb2 family SH3 domains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978303      PMCID: PMC2286729          DOI: 10.1110/ps.03470504

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  29 in total

1.  A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules.

Authors:  Amy Hin Yan Tong; Becky Drees; Giuliano Nardelli; Gary D Bader; Barbara Brannetti; Luisa Castagnoli; Marie Evangelista; Silvia Ferracuti; Bryce Nelson; Serena Paoluzi; Michele Quondam; Adriana Zucconi; Christopher W V Hogue; Stanley Fields; Charles Boone; Gianni Cesareni
Journal:  Science       Date:  2001-12-13       Impact factor: 47.728

2.  Topography for independent binding of alpha-helical and PPII-helical ligands to a peroxisomal SH3 domain.

Authors:  Alice Douangamath; Fabian V Filipp; André T J Klein; Phil Barnett; Peijian Zou; Tineke Voorn-Brouwer; M Cristina Vega; Olga M Mayans; Michael Sattler; Ben Distel; Matthias Wilmanns
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

3.  Enhanced affinities and specificities of consolidated ligands for the Src homology (SH) 3 and SH2 domains of Abelson protein-tyrosine kinase.

Authors:  D Cowburn; J Zheng; Q Xu; G Barany
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

4.  Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G.

Authors:  G Posern; J Zheng; B S Knudsen; C Kardinal; K B Müller; J Voss; T Shishido; D Cowburn; G Cheng; B Wang; G D Kruh; S K Burrell; C A Jacobson; D M Lenz; T J Zamborelli; K Adermann; H Hanafusa; S M Feller
Journal:  Oncogene       Date:  1998-04-16       Impact factor: 9.867

Review 5.  Minimized proteins.

Authors:  B C Cunningham; J A Wells
Journal:  Curr Opin Struct Biol       Date:  1997-08       Impact factor: 6.809

6.  Improving SH3 domain ligand selectivity using a non-natural scaffold.

Authors:  J T Nguyen; M Porter; M Amoui; W T Miller; R N Zuckermann; W A Lim
Journal:  Chem Biol       Date:  2000-07

7.  The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.

Authors:  M Lewitzky; C Kardinal; N H Gehring; E K Schmidt; B Konkol; M Eulitz; W Birchmeier; U Schaeper; S M Feller
Journal:  Oncogene       Date:  2001-03-01       Impact factor: 9.867

8.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

9.  Pharmacological and behavioral analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors.

Authors:  A P Tamiz; B C Bandyopadhyay; J Zhang; J L Flippen-Anderson; M Zhang; C Z Wang; K M Johnson; S Tella; A P Kozikowski
Journal:  J Med Chem       Date:  2001-05-10       Impact factor: 7.446

10.  Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors.

Authors:  J T Nguyen; C W Turck; F E Cohen; R N Zuckermann; W A Lim
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

View more
  3 in total

1.  Quantitative relation between intermolecular and intramolecular binding of pro-rich peptides to SH3 domains.

Authors:  Huan-Xiang Zhou
Journal:  Biophys J       Date:  2006-08-04       Impact factor: 4.033

2.  Investigation of monovalent and bivalent enantioselective molecular recognition by electrospray ionization-mass spectrometry and tandem mass spectrometry.

Authors:  Kevin A Schug; Manishkumar D Joshi; Petr Frycák; Norbert M Maier; Wolfgang Lindner
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-17       Impact factor: 3.109

Review 3.  Grb2 signaling in cell motility and cancer.

Authors:  Alessio Giubellino; Terrence R Burke; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2008-08       Impact factor: 6.902

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.